EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg Ulcers

András L Kovács, Csaba Gyömörei, Szabina Horváth iD, Viktória Németh iD, Réka Dudley iD, Zsuzsanna Nagy, Tímea Berki, Zsuzsanna Lengyel, Rolland Gyulai iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von András L Kovács und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Oncodermatology, Medical School, University of Pécs, 7622 Pécs, Hungary. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Leg Ulcer, Endothelial Cells, Antibodies, Antiphospholipid. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiphospholipid antibody (aPL)-induced activation of the mTOR (mammalian target of rapamycin) signaling pathway in endothelial cells plays a role in the pathogenesis of vascular lesions in antiphospholipid syndrome (APS). However, there are no data on whether this mechanism also contributes to the development of skin ulcers commonly observed in APS. We investigated the activation of mTOR in skin specimens from aPL-positive and aPL-negative patients with leg ulcers. Patients with leg ulcers who had primary or secondary APS or no detectable aPLs were included in the study. Biopsies were taken from the ulcer edges and the adjacent non-ulcerated skin areas. Activation of mTORC1 (mTOR Complex1) and mTORC2 (mTOR Complex2) in endothelial cells was determined by immunohistochemical analysis of phosphorylated ribosomal S6 protein (pS6RP) and phosphorylated protein kinase B (pAKT), respectively. In all aPL-positive patients, regardless of whether they had primary or secondary APS, we found a positive immunohistochemical reaction to pS6RP (mTORC1 activation) in the endothelial cells of the ulcer samples. On the other hand, pS6RP could not be detected in samples from aPL-negative chronic venous ulcers. Furthermore, pS6RP was not present in samples taken from the unaffected skin adjacent to the ulcers in aPL-positive patients. The pAKT reaction (mTORC2) was negative in both aPL-positive and aPL-negative patients, both in the ulcers and in the periulcer skin. Activation of the mTOR pathway may contribute to ulcer development in APS. The mTORC1 may be a target for therapeutic modification in APS-associated skin ulcers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesLeg UlcerEndothelial CellsAntibodies, AntiphospholipidAntiphospholipid SyndromeHumansMaleFemaleMiddle AgedSignal TransductionAgedAdultPhosphorylationMechanistic Target of Rapamycin Complex 2Mechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktSkin

Stichwörter der Autor:innen

antiphospholipid antibodyantiphospholipid syndromeleg ulcermammalian target of rapamycin

Substanzen

TOR Serine-Threonine KinasesAntibodies, AntiphospholipidMTOR protein, humanMechanistic Target of Rapamycin Complex 2Mechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Oncodermatology, Medical School, University of Pécs, 7622 Pécs, Hungary.
  • Department of Pathology, Medical School, University of Pécs, 7622 Pécs, Hungary.
  • Department of Dermatology, Veszprém County Csolnoky Ferenc Hospital, 8200 Veszprém, Hungary.
  • 2nd Department of Internal Medicine and Nephrological Center, Medical School, University of Pécs, 7622 Pécs, Hungary.
  • Department of Immunology and Biotechnology, Medical School, University of Pécs, 7622 Pécs, Hungary.
  • Department of Dermatology and Allergology, Albert-Szent Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary.

ORCID-Profile: Szabina Horváth, Viktória Németh, Réka Dudley, Rolland Gyulai

Förderung

  • Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund

Zitieren

APA

Kovács, A. L., Gyömörei, C., Horváth, S., Németh, V., Dudley, R., Nagy, Z., Berki, T., Lengyel, Z., & Gyulai, R. (2025). Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg Ulcers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062750

Vancouver

Kovács AL, Gyömörei C, Horváth S, Németh V, Dudley R, Nagy Z, et al. Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg Ulcers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062750

BibTeX
@article{Kovcs2025,
  author = {Kovács, András L and Gyömörei, Csaba and Horváth, Szabina and Németh, Viktória and Dudley, Réka and Nagy, Zsuzsanna and Berki, Tímea and Lengyel, Zsuzsanna and Gyulai, Rolland},
  title = {Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg Ulcers},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062750}
}
Kostenlos starten →